Satoshi Takagi

1.5k total citations
30 papers, 879 citations indexed

About

Satoshi Takagi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Satoshi Takagi has authored 30 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Satoshi Takagi's work include Platelet Disorders and Treatments (7 papers), Lymphatic System and Diseases (7 papers) and Immunotherapy and Immune Responses (5 papers). Satoshi Takagi is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Lymphatic System and Diseases (7 papers) and Immunotherapy and Immune Responses (5 papers). Satoshi Takagi collaborates with scholars based in Japan, United States and Italy. Satoshi Takagi's co-authors include Naoya Fujita, Miho Takami, Shigeo Sato, Tomoko Oh‐hara, Ai Takemoto, Sumie Koike, Hiroyuki Osada, Siro Simizu, Yuji Mishima and Kiyohiko Hatake and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Satoshi Takagi

26 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Takagi Japan 14 571 372 174 164 145 30 879
Brett H. Herzog United States 12 631 1.1× 333 0.9× 383 2.2× 112 0.7× 121 0.8× 17 1.1k
Claudia Le United States 5 465 0.8× 386 1.0× 189 1.1× 131 0.8× 60 0.4× 5 1.1k
Kalyan C. Nannuru United States 16 494 0.9× 376 1.0× 274 1.6× 190 1.2× 53 0.4× 20 886
Angela Pennisi United States 15 479 0.8× 345 0.9× 134 0.8× 137 0.8× 377 2.6× 40 902
Miho Takami Japan 10 412 0.7× 246 0.7× 102 0.6× 66 0.4× 90 0.6× 18 600
Ai Takemoto Japan 9 421 0.7× 231 0.6× 127 0.7× 70 0.4× 62 0.4× 15 592
Valérie Méresse France 13 335 0.6× 314 0.8× 117 0.7× 90 0.5× 218 1.5× 23 830
Zuzana Čierna Slovakia 18 420 0.7× 340 0.9× 126 0.7× 237 1.4× 40 0.3× 47 930
Anna-Maria Larsson Sweden 14 480 0.8× 232 0.6× 226 1.3× 345 2.1× 47 0.3× 27 859
Nadia Coltella Italy 16 194 0.3× 387 1.0× 109 0.6× 206 1.3× 108 0.7× 24 709

Countries citing papers authored by Satoshi Takagi

Since Specialization
Citations

This map shows the geographic impact of Satoshi Takagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Takagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Takagi more than expected).

Fields of papers citing papers by Satoshi Takagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Takagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Takagi. The network helps show where Satoshi Takagi may publish in the future.

Co-authorship network of co-authors of Satoshi Takagi

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Takagi. A scholar is included among the top collaborators of Satoshi Takagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Takagi. Satoshi Takagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Tingqin, Satoshi Takagi, Sumie Koike, & Ryohei Katayama. (2025). Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma. Cell Death Discovery. 11(1). 340–340.
2.
Takeuchi, Makoto, et al.. (2025). Osteocyte-like differentiation of osteosarcoma by inorganic phosphate. Differentiation. 146. 100912–100912.
3.
Takagi, Satoshi, Sumie Koike, Miho Takami, et al.. (2024). Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma. Oncogene. 44(12). 794–804.
4.
Uchibori, Ken, Ai Takemoto, Sumie Koike, et al.. (2024). MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer. Cancer Letters. 604. 217220–217220.
5.
Takemoto, Ai, Satoshi Takagi, Nobuhiko Gyobu, et al.. (2022). Targeting Podoplanin for the Treatment of Osteosarcoma. Clinical Cancer Research. 28(12). 2633–2645. 19 indexed citations
6.
Shimizu, Yuki, Koutaroh Okada, Jun Adachi, et al.. (2022). GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer. npj Precision Oncology. 6(1). 16–16. 13 indexed citations
7.
Yanagitani, Noriko, Sumie Koike, Siew‐Kee Low, et al.. (2022). Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer. Cancer Science. 113(11). 3888–3900. 8 indexed citations
8.
Yoshizawa, Takahiro, Ken Uchibori, Mitsugu Araki, et al.. (2021). Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity. npj Precision Oncology. 5(1). 32–32. 16 indexed citations
9.
Takagi, Satoshi, Sumie Koike, Ai Takemoto, et al.. (2021). Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Oncogene. 40(36). 5548–5558. 33 indexed citations
10.
Sakata, Seiji, Bo Gong, Yosuke Seto, et al.. (2021). Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation. JCI Insight. 7(1). 37 indexed citations
11.
Takemoto, Ai, et al.. (2021). Novel knock‐in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin–targeting agents. Cancer Science. 112(6). 2299–2313. 3 indexed citations
12.
Takagi, Satoshi, Shokichi Tsukamoto, Jihye Park, et al.. (2018). Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation. Clinical Cancer Research. 24(10). 2430–2439. 45 indexed citations
13.
Tsukamoto, Shokichi, Marianne Bengtson Løvendorf, Jihye Park, et al.. (2018). Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche. Leukemia. 32(8). 1739–1750. 33 indexed citations
14.
Sato, Eiichi, Atsushi Togawa, Yasumasa Kawano, et al.. (2018). Community-acquired Disseminated <i>Exophiala dermatitidis</i> Mycosis with Necrotizing Fasciitis in Chronic Graft-versus-host Disease. Internal Medicine. 58(6). 877–882. 6 indexed citations
15.
Takeuchi, Shinji, Koji Fukuda, Tadaaki Yamada, et al.. (2017). Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation. Cancer Science. 108(4). 696–703. 12 indexed citations
16.
Takemoto, Ai, Satoshi Takagi, Miho Takami, et al.. (2017). A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis. Scientific Reports. 7(1). 42186–42186. 98 indexed citations
17.
Takagi, Satoshi, Ai Takemoto, Miho Takami, Tomoko Oh‐hara, & Naoya Fujita. (2014). Platelets promote osteosarcoma cell growth through activation of the platelet‐derived growth factor receptor‐Akt signaling axis. Cancer Science. 105(8). 983–988. 74 indexed citations
18.
Nakazawa, Youya, Satoshi Takagi, Shigeo Sato, et al.. (2011). Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti‐Aggrus/podoplanin antibodies. Cancer Science. 102(11). 2051–2057. 48 indexed citations
19.
Takagi, Satoshi, Siro Simizu, & Hiroyuki Osada. (2009). RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription. Cancer Research. 69(4). 1502–1508. 82 indexed citations
20.
Misawa, Ryosuke, et al.. (2008). Primary Colonic Signet Ring Cell Carcinoma Presenting Carcinocythemia: An Autopsy Case. Case Reports in Gastroenterology. 2(3). 301–307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brett H. Herzog Breakdown of academic impact, for papers by Claudia Le Breakdown of academic impact, for papers by Kalyan C. Nannuru Breakdown of academic impact, for papers by Angela Pennisi Breakdown of academic impact, for papers by Miho Takami Breakdown of academic impact, for papers by Ai Takemoto Breakdown of academic impact, for papers by Valérie Méresse Breakdown of academic impact, for papers by Zuzana Čierna Breakdown of academic impact, for papers by Anna-Maria Larsson Breakdown of academic impact, for papers by Nadia Coltella
Rankless by CCL
2026